KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bristol Myers Squibb (BMY) EBT Margin (2016 - 2025)

Historic EBT Margin for Bristol Myers Squibb (BMY) over the last 17 years, with Q4 2025 value amounting to 11.76%.

  • Bristol Myers Squibb's EBT Margin rose 103400.0% to 11.76% in Q4 2025 from the same period last year, while for Dec 2025 it was 19.36%, marking a year-over-year increase of 367000.0%. This contributed to the annual value of 19.36% for FY2025, which is 367000.0% up from last year.
  • Bristol Myers Squibb's EBT Margin amounted to 11.76% in Q4 2025, which was up 103400.0% from 25.48% recorded in Q3 2025.
  • Over the past 5 years, Bristol Myers Squibb's EBT Margin peaked at 26.52% during Q1 2025, and registered a low of 97.06% during Q1 2024.
  • Over the past 5 years, Bristol Myers Squibb's median EBT Margin value was 15.9% (recorded in 2021), while the average stood at 10.97%.
  • As far as peak fluctuations go, Bristol Myers Squibb's EBT Margin crashed by -1214900bps in 2024, and later skyrocketed by 1235800bps in 2025.
  • Over the past 5 years, Bristol Myers Squibb's EBT Margin (Quarter) stood at 15.5% in 2021, then increased by 5bps to 16.3% in 2022, then decreased by -11bps to 14.59% in 2023, then plummeted by -90bps to 1.42% in 2024, then skyrocketed by 729bps to 11.76% in 2025.
  • Its last three reported values are 11.76% in Q4 2025, 25.48% for Q3 2025, and 14.45% during Q2 2025.